We suggest reserving the term PSMA-negative or non-PSMA-expressing PCa for lesions with equal or lower PSMA expression than the surrounding prostate background of the same patient, as suggested by the E-PSMA guidelines [2,6]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.